A detailed history of Quantinno Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Quantinno Capital Management LP holds 14,828 shares of BCRX stock, worth $134,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,828
Previous 10,731 38.18%
Holding current value
$134,193
Previous $81,000 37.04%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$7.03 - $8.43 $28,801 - $34,537
4,097 Added 38.18%
14,828 $111,000
Q3 2024

Nov 14, 2024

BUY
$6.41 - $8.69 $68,785 - $93,252
10,731 New
10,731 $81,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.68B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.